OSR Health, Inc. announced that Nasdaq confirmed its Shareholder Loyalty Contingent Value Rights (CVR) program will not trigger a mechanical price adjustment to the common stock upon distribution or delivery of additional shares. The record date for eligibility is August 14, 2026. This clarification ensures enrolled shareholders receive additional shares at no cost as price milestones are met, with value determined by market forces rather than exchange adjustments. OSR Health operates in the healthcare industry, specifically advancing biomedical innovations through immuno-oncology, regenerative biologics, and medical device technologies.